Abstract:Patients with Barrett's esophagus (BE)/columnar lined esophagus (CLE) and adenocarcinoma are increasing, in whom 0.61% BE/CLE would develop to adenocarcinoma. The prognosis of esophageal cancer is related to the tumor stage at diagnosis. To standardize the screening, diagnosis and therapy of BE and adenocarcinoma in China, 31 digestive diseases and digestive endoscopy experts and digestive histologists drafted the consensus on the basis of clinical experience and references. The consensus defined BE as a complication of gastroesophageal reflux disease. The normal distal squamous epithelial lining is replaced by columnar epithelial. The squamous-columnar junction (SCJ) is above the gastroesophageal junction (GEJ) ≥1 cm and proved by endoscopy and histology. Adenocarcinoma developing in BE mucosa is called BE adenocarcinoma. The early BE adenocarcinoma is divided into 4 stages: M1, M2, M3 and M4, according to the depth of tumor infiltration without expanding beyond mucosa. Because 90% esophageal cancers are esophageal squamous cell carcinoma (ESCC) in China, this consensus emphasizes the significance of screening BE and adenocarcinoma in esophageal cancers. The diagnosis of BE should meet the following criteria: under endoscopy, the normal distal squamous epithelial lining is replaced by columnar epithelial (SCJ is above the GEJ ≥1cm), which is confirmed by histology. The lesion should be further assessed by electron staining endoscopy such as narrow band imaging (NBI), flexile spectral imaging color enhancement (FICE), i-scan, and endoscopic ultrasonography (EUS) to choose the optimal therapy. Endoscopic resection such as endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) is preferred. Radiofrequency ablation (RFA), photodynamic therapy (PDT), cryotherapy, Argon plasma coagulation (APC) are alternative therapeutic regimens yet should be administrated cautiously. The standardized histologic result is very important, which can be used to assess the response effect, further treatment and follow-up schedule. It is recommended that the follow-up would better be done with high resolution endoscope. Patients without intestinal metaplasia in the four quadrants of BE and the length <3 cm is recommended to be excluded from the follow-up. BE with intestinal metaplasia<3 cm is recommended only follow-up for 3-5 years. BE and metaplasia≥3 cm is recommended to be observed every 2-3 years.

A Self-control Study of Acetic Acid Stain-guided Biopsies in Detection of Intestinal Metaplasia and Dysplasia in Barrett’s Esophagus

Diagnostic Value of Autofluorescence Imaging Combined with Narrow Band Imaging in Intraepithelial Neoplasia of Barrett's Esophagus.

Intestinal metaplasia in follow-up endoscopies among Asian patients with short-segment Barrett's esophagus: Regression, sampling error, and associated factors

A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus

Ab-Pas As A Potential Alternative for the Diagnosis of Intestinal Metaplasia

Short-segment Barrett’s Esophagus and Cardia Intestinal Metaplasia: A Comparative Analysis

Computer-Simulated Biopsy Marking System for Endoscopic Surveillance of Gastric Lesions: A Pilot Study

Distinction Between Short-Segment Barrett'S Esophageal and Cardiac Intestinal Metaplasia

Auto Fluorescence Imaging Combined with Narrow Band Imaging Technology Research for the Diagnosis of Early Neoplasia in Barrett's Esophagus

Probe-based endomicroscopy for in vivo detection of gastric intestinal metaplasia and neoplasia: a multicenter randomized controlled trial

AI-assisted Identification of Intrapapillary Capillary Loops in Magnification Endoscopy for Diagnosing Early-Stage Esophageal Squamous Cell Carcinoma: a Preliminary Study

A Single-center Pilot Study on the Efficacy and Safety of Acetic Acid-enhanced Magnifying Endoscopy with Narrow-Band Imaging for Diagnosis of Colorectal Epithelial Neoplasms

A Study on Intestinal Metaplasia in Barrett's Esophagus

[The Chinese consensus for screening, diagnosis and management of Barrett's esophagus and early adenocarcinoma(2017, Wanning)]

Real-time diagnosis of Barrett's esophagus: a prospective, multicenter study comparing confocal laser endomicroscopy with conventional histology for the identification of intestinal metaplasia in new users

How to Diagnose and Manage Patients with Barrett's Esophagus in China

Comparative Study of Two Different Treatment Methods on Barrett's Esophagus

A Multicenter Prospective Evaluation of Four Enhanced Magnifying Endoscopy for Diagnosis of Precancerous Lesions and Early Gastric Cancers

Advance of Study on Bile Acids in Barrett's Carcinogenesis

Multicenter, Prospective Trial Of Non-Endoscopic Biomarker-Driven Detection Of Barrett'S Esophagus And Esophageal Adenocarcinoma

Narrow-Band Imaging and White-Light Endoscopy with Optical Magnification in the Diagnosis of Dysplasia in Barrett'S Esophagus: Results of the Asia-Pacific Barrett'S Consortium